The Vertical

The Vertical The Vertical is the voice of international, immigrant, and minority entrepreneurship.

We’re excited to host “AI in Private Equity: Redefining Risk, Speed & Strategy” — a high-impact conversation on how gene...
12/04/2025

We’re excited to host “AI in Private Equity: Redefining Risk, Speed & Strategy” — a high-impact conversation on how generative AI is transforming the future of private markets.

From deal-sourcing to due diligence, portfolio management to infrastructure investment, AI is changing how capital moves. If you’re a PE investor, fund manager, founder, or digital-transformation leader, this room is for you.

📅 What’s happening:
• A top-tier panel on AI-driven diligence & exit planning
• Real talk on turning AI pilots into profit-driving infrastructure
• Networking with operators, investors & tech founders

🎙️ Our speakers:
• Gelila Zenebe Bekele, Director, Aone Partners — ex-BlackRock, SaaS acquisitions, HBR-published
• Mason Lender, CEO & Co-Founder, Vantager — powering diligence for LPs with $100B+ AUM
• Nikita Sharkov, VP, Long Arc Capital — scaling advanced AI across portfolios
• Moderated by: Ilona Limonta-Volkova, Principal at Bright Ventures & host of NPR’s Money Memories

Big thanks to our sponsor CLA (CliftonLarsonAllen) for supporting this event.

See flyer for event details.

Link in bio to register.

Happy Thanksgiving from all of us at The Vertical.We are so grateful for another year of being with you, so today, we pa...
11/27/2025

Happy Thanksgiving from all of us at The Vertical.

We are so grateful for another year of being with you, so today, we pause to say thank you.

Thank you to every founder, operator, investor, and friend who has shown up for this community—online, onstage, and in every conversation that has shaped our journey this year.

To our partners: thank you for believing in a vision that sits at the intersection of innovation, impact, and global ambition. Your support fuels the work we do.

To our community: your energy, curiosity, and commitment to building what’s next continue to inspire us. Every story shared, every insight exchanged, and every event attended has made this year unforgettable.

Here’s to more learning, more breakthroughs, and more moments that move the world forward.

We’re grateful. We’re excited. And we’re just getting started.

Happy Thanksgiving!

Everyone wants in on America’s chip boom — but the reality on the ground is complicated.Massive bets like Micron Technol...
11/25/2025

Everyone wants in on America’s chip boom — but the reality on the ground is complicated.

Massive bets like Micron Technology ’s $100B Megafab in New York and TSMC's $165B expansion in Arizona are pulling founders from all over the world to the U.S. market.

Global companies in robotics, photonics, industrial equipment, and packaging are exploring entry points.

Everyone sees the opportunity — especially with AI driving demand for advanced chips.

But behind the excitement?

Many are still in “wait and see” mode.

Some big hurdles:

⚠️ Multi-year delays on major fabs
👷 Severe talent shortages — TSMC even had to fly in technicians from Taiwan
🌪️ Political uncertainty making investors nervous
📉 Low confidence among smaller suppliers

To read full story tap link in bio.

:UPCOMING EVENT ANNOUNCEMENT We are thrilled to invite you to “AI in Private Equity: Redefining Risk, Speed, and Strateg...
11/20/2025

:
UPCOMING EVENT ANNOUNCEMENT

We are thrilled to invite you to “AI in Private Equity: Redefining Risk, Speed, and Strategy”.

Date: Dec. 11, 2025

📍 Venue: One Grand Central Place

🔍 What we’ll explore:

Accelerating diligence & exit ex*****on with AI.

Driving operational value-creation in PE portfolios via predictive analytics and automation.

The emergence of AI as an asset class — infrastructure plays, mega-deals, and what they signal.

Managing AI risk, governance, and aligning initiatives with investor expectations.

Moving beyond pilot projects — how mid-market PE firms scale AI deployments.

🎯 Who this is for:
If you're a private-equity GP or LP, investment professional, CIO, operating partner, digital-transformation executive or tech-investor keen to understand how AI is reshaping deal sourcing, underwriting, portfolio management and infrastructure — this is for you.

🔗 Register now to secure your spot.

We’re excited to bring together leading minds at the intersection of AI and private markets — and we’d love to see you there. Mark your calendar. Let’s rethink what’s possible.

What started as a mission to fight disinformation in Ukraine has now become a powerful shield for Fortune 500 companies....
11/11/2025

What started as a mission to fight disinformation in Ukraine has now become a powerful shield for Fortune 500 companies.

That’s the story of LetsData — a startup built in the middle of chaos by Ksenia Iliuk is now leading the charge against AI-driven security threats.

In the early days of the war, their tools helped detect and counter misinformation in real time. But as the world evolved, so did the threat — from troll farms to AI-generated narratives capable of damaging brands, influencing markets, and distorting facts.

Today, LetsData monitors over 100 million online sources in more than 50 languages, giving companies an edge against fast-moving disinformation and synthetic media. As their team puts it, “we saw a spike in demand from companies and governments requiring advanced InfoOps detection.”

The same technology that once helped defend a nation is now helping protect the digital reputation and integrity of global enterprises.

Continue reading by clicking link (see comment section)

D-Day!The wait is over, our event themed, Healthcare + AI: Integrating AI into Real Workflows is happening today, Novemb...
11/11/2025

D-Day!

The wait is over, our event themed, Healthcare + AI: Integrating AI into Real Workflows is happening today, November 11, 2025

Join healthcare leaders, clinicians, and AI innovators as we move beyond the buzz to explore how top-tier health systems are actually implementing AI in their real-world operations.

Expect deep dives into:
💡 Embedding AI into clinical workflows
⚖️ Navigating compliance, liability & trust
🩺 Lessons from early adopters — what’s working, what’s not
🚀 The next frontier of predictive and autonomous tools

🎙 We have a special line up of speakers which includes:

▶️Rachael Linn Spooner

▶️Abigail Baldwin Medsker MBA MSN RN

▶️ Moran Snir

🧭 Moderated by Allan Gobbs

A special thank you to our event sponsors, Perkins Coie and YCare for powering this important dialogue on the future of healthcare innovation. 🙌

Join the conversation because it’s happening today.

⌛⌛We’re counting down to our upcoming event: Healthcare + AI: Integrating AI into Real Workflows, happening next Tuesday...
11/06/2025

⌛⌛
We’re counting down to our upcoming event: Healthcare + AI: Integrating AI into Real Workflows, happening next Tuesday, November 11

Join top voices in healthcare innovation as they dive into how AI is being truly integrated into clinical operations — not just discussed.

Here’s what’s on the agenda:
💡 Embedding AI into clinical workflows today

⚖️ Navigating compliance, liability & trust

🩺 Lessons from early adopters — what’s working, what’s not

🚀 What’s next: predictive tools, ambient documentation & autonomous triage

🎙 Speakers include:

Rachael-Linn Spooner, Northwell Health

Abigail Baldwin Medsker MBA MSN RN

Moran Snir , Nest Genomics (YC W22)

🧭 Moderated by Allan Gobbs

Join us for a night of learning, networking, and big ideas shaping the next chapter of healthcare innovation.

A huge thank you to our sponsor, Perkins Coie, for supporting this important conversation on the future of healthcare innovation.

📢📢📢The Vertical is thrilled to announce our lineup of industry leaders for the upcoming Healthcare + AI event happening ...
11/06/2025

📢📢📢

The Vertical is thrilled to announce our lineup of industry leaders for the upcoming Healthcare + AI event happening on November 11, 2025.

These trailblazers are driving the real-world integration of AI in healthcare:

Rachael Linn Spooner VP Strategy & Business Development, Northwell Health

Abigail Baldwin Medsker MBA MSN RN , Senior Director, Digital Health Innovation, MSK

Moran Snir, Co-founder & CEO, Nest Genomics (YC W22)

Moderated by Allan Gobbs an managing partner, ATEM Capital

Together, they’ll unpack:
💡 How AI is being embedded into clinical workflows today
⚖️ The challenges around compliance, liability & trust
🩺 Case studies from early adopters
🚀 The future — predictive tools, ambient documentation & autonomous triage

This won’t be another theoretical AI talk — it’s a conversation on what’s working, what’s not, and what’s next.

🗓 Date: November 11, 2025
🔗 RSVP: See link in comments

🚨Upcoming Event Alert: Healthcare + AI — Integrating AI into Real Workflows This November, The Vertical alongside Victor...
11/04/2025

🚨
Upcoming Event Alert: Healthcare + AI — Integrating AI into Real Workflows

This November, The Vertical alongside Victoria Zavyalova and Gadareth Higgs, PhD,will host a timely conversation on how top-tier health systems are actually integrating AI into their real-world operations.

🗓 Date: Tuesday, November 11, 2025

The event will bring together healthcare leaders, clinicians, AI innovators, and investors to explore:

💡 How AI is being embedded into clinical workflows today

⚖️ Navigating compliance, liability, and trust in AI-driven decisions

🩺 Real case studies from early adopters — what’s working, what’s not

🚀 What’s next: predictive tools, ambient documentation, and autonomous triage

🎙 Speakers include:

Rachael-Linn Spooner, VP Strategy & Business Development, Northwell Health

Abigail Baldwin Medsker, Senior Director, Digital Health Innovation, MSK

Moran Snir , Co-founder & CEO, Nest Genomics

Moderated by Allan Gobbs, managing partner, ATEM Capital

This conversation will move beyond the hype to focus on implementation, trust, and measurable impact.

Join us for an evening of learning, networking, and collaboration as we explore what the next phase of healthcare + AI looks like.

Many thanks to our sponsor Perkins Coie and event partner ATEM Capital for their support.

What’s driving hundreds of Israeli startups to set up shop in New York instead of Tel Aviv?Here's what we know:Nearly 45...
10/17/2025

What’s driving hundreds of Israeli startups to set up shop in New York instead of Tel Aviv?

Here's what we know:

Nearly 45% of new Israeli-founded startups in 2025 are incorporating abroad — and the U.S. is their top choice. For many, it’s not just about location; it’s about access to capital, investor confidence, and a stable business climate.

New York City, in particular, has become a magnet. It now hosts over 560 Israeli-founded startups, cutting across cybersecurity, fintech, AI, and software. The bridge between Tel Aviv and NYC has never looked stronger.

But this shift also raises new concerns. As more founders move operations abroad, Israel risks losing a key part of its innovation engine — its local talent and startup culture.

Still, there’s another side to this story: opportunity. This migration shows how founders are rethinking geography and resilience in uncertain times — building global even when they start local.

Link in bio to read.

10/17/2025

Looking back to The Vertical’s Climate Week NYC event on Climate Tech & AI Infrastructure, where the conversation went beyond data and deals — it touched imagination. 🌍✨

One of our sponsors, Law by Levin brought that spirit to life with a poem that resonated deeply across the room:

“From Lagos to London, São Paulo to Seoul, founders train AI on the world we call home.
Climate is the market, code is the tool, venture the fuel.
You’re not waiting for permission; you’re rewriting the rules before the earth can cool.”

In just a few lines, they captured what this movement is all about: the global nature of climate innovation, the power of AI as an enabler, and the urgency founders and VCs share in building solutions that matter.

We’re grateful to Law by Levin for supporting our event and for reminding us that addressing climate change isn’t only about technology — it’s also about creativity, courage, and vision.

Here’s to rewriting the rules together.

"No foreign capital in biotech is ever neutral", but how true is this?A recent story about FastWave Medical sheds some l...
10/17/2025

"No foreign capital in biotech is ever neutral", but how true is this?

A recent story about FastWave Medical sheds some light.

The U.S. startup raised $40 million in Series A funding from China’s Grand Pharmaceutical Group — but that deal soon became messy.

The investor allegedly withheld payments, blocked FastWave from raising more money in the U.S., and later aligned with a rival company in China.

What started as growth funding quickly turned into a battle over control, intellectual property, and trust.

The fallout even drew attention from CFIUS, the U.S. committee that reviews foreign investments.

It’s a timely reminder that while U.S. biotech funding has dropped sharply — from $5.5 billion in Q1 2020 to around $900 million in Q2 2025 — not every investor relationship is worth the risk.

When looking for funding don’t just look at the money. Ask what comes with it — control, data access, or political exposure.

If you’re a founder, investor, or policymaker, this is your cue to rethink how we fund innovation safely.

What do you think — can U.S. biotech thrive without risky foreign capital?

Read the full story by clicking in bio

Address

220 East 23rd Street, Suite 400
New York, NY
10010

Alerts

Be the first to know and let us send you an email when The Vertical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share